CH-157 cells |
Function assay |
2.5 μM |
3 hours |
LB-100 significantly enhanced the proportion of cells in G2/M. |
29199006 |
U251 cells |
Function assay |
2 μM |
3 hours and 6 hours |
treatment with 2 μM LB100 reduced PP2A activity to 61% of control cells after both three and six hours of LB100 exposure. |
25939762 |
Huh-7 |
PP2A activity assays |
5 μmol/L |
2 h |
reduced the activity of PP2A to about 70% |
24867249 |
HepG2 |
PP2A activity assays |
5 μmol/L |
2 h |
reduced the activity of PP2A to about 70% |
24867249 |
HL-7702 |
PP2A activity assays |
5 μmol/L |
2 h |
reduced the activity of PP2A to about 70% |
24867249 |
OVCAR-8 |
Cytotoxicity assay |
|
72 h |
IC50 = 5.5 ± 0.5 μM |
25376608 |
PEO-4 |
Cytotoxicity assay |
|
72 h |
IC50 = 5 ± 0.6 μM |
25376608 |
SKOV-3 |
Cytotoxicity assay |
|
72 h |
IC50 = 10.1 ± 1.8 μM |
25376608 |
PEO-6 |
Cytotoxicity assay |
|
72 h |
IC50 = 5.1 ± 0.2 μM |
25376608 |
PEO1-Brca2 Missense |
Cytotoxicity assay |
|
72 h |
IC50 = 6.2 ± 1.5 μM |
25376608 |
PEO1-Brca2 STOP |
Cytotoxicity assay |
|
72 h |
IC50 = 6.2 ± 1.0 μM |
25376608 |
D341 cells |
Cell viability assay |
|
|
IC50=1.9 μM, using XTT assays |
26799670 |
DAOY cells |
Cell viability assay |
|
|
IC50=2.9 μM, using XTT assays |
26799670 |
D283 cells |
Cell viability assay |
|
|
IC50=0.9 μM, using XTT assays |
26799670 |